What is Comstock Inc.'s bioleum — operating income?

Comstock Inc. (LODE) reported bioleum — operating income of -$5.64M in Q1 2026.

How has Comstock Inc.'s bioleum — operating income changed year-over-year?

Comstock Inc.'s bioleum — operating income decreased by 111.8% year-over-year, from -$2.66M to -$5.64M.

What does bioleum — operating income mean?

Measures the profit or loss generated by the Bioleum segment after deducting operating expenses from revenues. It is a primary indicator of the segment's core operational health and its ability to generate sustainable returns without relying on non-operating activities.

Comstock Inc. LODE Bioleum — Operating Income

Other segment segments

Corporate And Other

-$2.18M+7.7%

Similar metrics at other companies

JAN

JANBiotech — Operating Income

-$177K+67.2%

DHRBiotechnology — Operating Income (Loss)

$534M+21.1%

TMOLaboratory Products and Biopharma Services — Operating Income (Loss)

$778M+6.4%

DHRLife Sciences — Operating Income (Loss)

$225M+11.9%

BDXBioPharma Systems — Operating Income (Loss)

$225M+0.4%

ASHLife Sciences — Operating Income

$35M+25.0%

Other financials

Income statement

See full

Revenue$313.5K-60.1%

Gross profit-$286.4K-184%

Operating income-$8.9M-27.1%

Net income-$9.4M-3.2%

EPS (diluted)-$3.01-450%

Balance sheet

See full

Cash & equivalents$53.0M+212%

Total debt$257.3K-98.8%

Total equity$156.4M—

Total assets$218.1M+28.6%

Cash flow

See full

Operating cash flow-$5.8M-17.3%

CapEx--100%

Free cash flow-$3.5M+2.7%

Valuation

See full

Market cap$302.13M+177%

Enterprise value$249.42M+118%

P/S279.4×+247×

Profitability

See full

Gross margin-116.4%-177pp

Operating margin-3,703.7%-7,510pp

Net margin-4,010%-13,152pp

FCF margin-462.3%-171pp

Returns & leverage

See full

Return on equity-51.5%-12.9pp

Debt / equity0×—

Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Comstock Inc.'s bioleum — operating income?: Comstock Inc. (LODE) reported bioleum — operating income of -$5.64M in Q1 2026.
How has Comstock Inc.'s bioleum — operating income changed year-over-year?: Comstock Inc.'s bioleum — operating income decreased by 111.8% year-over-year, from -$2.66M to -$5.64M.
What does bioleum — operating income mean?: Measures the profit or loss generated by the Bioleum segment after deducting operating expenses from revenues. It is a primary indicator of the segment's core operational health and its ability to generate sustainable returns without relying on non-operating activities.